APA (7th ed.) Citation

Nägele, F., Pölzl, L., Graber, M., Hirsch, J., Mayr, A., Pamminger, M., . . . Holfeld, J. (2022). Safety and efficacy of direct cardiac shockwave therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): Study protocol for a randomized controlled trial—an update. Current controlled trials in cardiovascular medicine, 23(1), 988-13. https://doi.org/10.1186/s13063-022-06931-4

Chicago Style (17th ed.) Citation

Nägele, Felix, et al. "Safety and Efficacy of Direct Cardiac Shockwave Therapy in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting (the CAST-HF Trial): Study Protocol for a Randomized Controlled Trial—an Update." Current Controlled Trials in Cardiovascular Medicine 23, no. 1 (2022): 988-13. https://doi.org/10.1186/s13063-022-06931-4.

MLA (9th ed.) Citation

Nägele, Felix, et al. "Safety and Efficacy of Direct Cardiac Shockwave Therapy in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting (the CAST-HF Trial): Study Protocol for a Randomized Controlled Trial—an Update." Current Controlled Trials in Cardiovascular Medicine, vol. 23, no. 1, 2022, pp. 988-13, https://doi.org/10.1186/s13063-022-06931-4.